Monopar Therapeutics (MNPR) Total Non-Current Liabilities (2020 - 2026)
Monopar Therapeutics (MNPR) posted Total Non-Current Liabilities of $2.9 million for Q4 2025, up 9.5% sequentially from $2.6 million in Q3 2025, and down 44.99% YoY from $5.3 million in Q4 2024.
Powered by 
Analysis
Monopar Therapeutics (MNPR) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
Monopar Therapeutics has reported Total Non-Current Liabilities for 3 years, with the latest figure at $2.9 million in Q4 2025.
- Quarterly Total Non-Current Liabilities fell 44.99% year-over-year to $2.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.9 million (down 44.99% YoY) and the FY2025 annual result came in at $2.9 million, down 44.99% from the prior year.
- Total Non-Current Liabilities grew to $2.9 million in Q4 2025 per MNPR's latest filing, from $2.6 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $5.3 million in Q4 2024 and troughed at $1.5 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 5.92 Bn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 7.74 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 40.00 Mn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 3.92 Bn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 1.53 Bn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 1.88 Bn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 4.20 Bn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 9.32 Bn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 1.17 Bn |
| 10 | Monopar Therapeutics | 1.01 Bn | 957.41 Mn | - | 4.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.12 Mn |
| Dec 31, 2025 | 2.89 Mn |
| Sep 30, 2025 | 2.64 Mn |
| Jun 30, 2025 | 1.66 Mn |
| Mar 31, 2025 | 1.49 Mn |
| Dec 31, 2024 | 5.25 Mn |
| Sep 30, 2020 | 54,628.00 |
| Jun 30, 2020 | 75,021.00 |